Medical Condition

breast carcinoma

Total Trials

13

Recruiting Now

13

Trial Phases

Phase 2, EARLY_Phase 1, Phase 1

ClinicalMetric tracks all active clinical trials for breast carcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — breast carcinoma Clinical Trials

How many clinical trials are currently recruiting for breast carcinoma?

ClinicalMetric currently tracks 13 actively recruiting clinical trials for breast carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 13. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for breast carcinoma?

breast carcinoma research spans Phase 1 (2 trials), Phase 2 (5 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a breast carcinoma clinical trial?

Eligibility criteria for breast carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Top Sponsors

National Cancer Institute (NCI) 4 trials

Mayo Clinic 3 trials

Algemeen Ziekenhuis Maria Middelares 1 trial

Ohio State University Comprehensive Cancer Center 1 trial

University of Southern California 1 trial

Recruiting Clinical Trials

NCT06635980 Phase 2

Recruiting

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer

National Cancer Institute (NCI...

View Trial →

NCT06835426

Recruiting

High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins

Algemeen Ziekenhuis Maria Midd...

View Trial →

NCT06274034 EARLY_Phase 1

Recruiting

MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Impact of Dietary Inflammatory Potential on Breast Cancer Risk

Ohio State University Comprehe...

View Trial →

NCT06195306 Phase 2

Recruiting

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

National Cancer Institute (NCI...

View Trial →

NCT05941520 Phase 2

Recruiting

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

National Cancer Institute (NCI...

View Trial →

NCT02610426

Recruiting

Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer

National Cancer Institute (NCI...

View Trial →

NCT06422455

Recruiting

Access to Genetic Testing in Underserved Patients With Cancer

University of Southern Califor...

View Trial →

NCT06970288

Recruiting

Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

M.D. Anderson Cancer Center

View Trial →

NCT06954831 Phase 2

Recruiting

Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer

City of Hope Medical Center

View Trial →

Related Conditions

breast lobular carcinoma in situ (3) anatomic stage i breast cancer ajcc v8 (2) anatomic stage ii breast cancer ajcc v8 (2) anatomic stage iii breast cancer ajcc v8 (2) triple negative breast carcinoma (2) breast atypical hyperplasia (2) breast ductal carcinoma in situ (2) ovarian carcinoma (2) neuropathy (1) prostate cancer surgery (1) thyroid cancer (1) parathyroid adenomas (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology